|
NOTES ON BLOOD TRANSFUSIONA Blood Care Foundation Guide Introduction If blood of the wrong group is transfused to a patient, a transfusion
reaction can occur. This is due to antigens (Ags) on the transfused cells
reacting with antibodies (Abs) in the patient's plasma. Reactions, as described
in para 9 below, can vary from mild to fatal, but the most important ones are
due to Ags on the red blood cells (RBCs). RBC Blood Groups
The ABO System The ABO system was first described by Landsteiner in 1900. There are 3 Ags
in this system A, B and H. These Ags, which are determined by terminal sugars
attached to various proteins and glycolipids in the RBC membrane, are the most
common Ags on the RBC surface. The A and B Ags are co-dominant and H is
recessive. During the first 6 months of life, the body will produce so-called
"naturally occurring antibodies" to those Ags, which are lacking on
the RBC membrane. These Abs are thought to be produced as a result of
stimulation by Ags, found on the surface of normal bowel bacteria, which are
virtually identical to the ABO Ags. These ABO Abs are a mixture of IgM and IgG,
are complement fixing and have a very wide thermal range of reaction, being
active from 40 to 370C. They are capable of causing
intravascular haemolysis if blood of the wrong group is transfused. When Landsteiner described the ABO system, he initially
described 3 groups. Those that carried the A Ag, which he designated Group A,
those that carried the B Ag, which he designated Group B and those that carried
no Ags, which he designated Group Nought (0). The last group, Group 0, later
came to be corrupted to Group O. The next year he described a fourth group
where, as the A and B Ags are co-dominant, a person inheriting the A Ag from
one parent and the B Ag from the other will be group AB. The H Ag is recessive
and is carried by everyone, with the exception of less than 100 people in the
world, who are of the Bombay Group and who will not be discussed further.
People who only carry the H Ag are Group O, but those who are heterozygous, AH
or BH, will be Group A or B respectively. There is no difference in the
strength of reaction shown by heterozygous, AH or BH, and homozygous, AA or BB,
people. The ABO genes are found on chromosome 9. The Rhesus (Rh) system is slightly more complicated because
it is composed of 3 closely linked allelic genes on chromosome 1, each with 2
alleles, namely C and c, D and d, and E and e. A person
inherits one set of alleles of the 3 Rh genes, known as a haplotype, from each
parent, for example CDe from one parent and cde from the other.
C, D and E are dominant alleles and c, d and e are
recessive. Table 1 lists the common haplotypes with their frequency. The D Ag is highly immunogenic, being at least 20 times more
immunogenic than any of the other Rh Ags, and so its presence or absence
determines whether a person is Rh Positive or Rh Negative. The normal notation
for this is Rh (D) Pos or Rh (D) Neg. The + and - signs are never used to
indicate Pos and Neg as these can so easily be altered, especially - to +. Abs
can be raised to all the alleles except d, which is presumed to be
amorphic. There are virtually no naturally occurring Abs to the Rh Ags, but the
transfusion of Rh (D) Pos blood to a Rh (D) Neg recipient usually causes the
formation of anti-D IgG Abs, which can cause a haemolytic reaction should a
further transfusion of Rh (D) Pos blood be given. More importantly anti-D Abs
are a potent causation of haemolytic disease of the newborn (HDN). Table 1. Frequency of common Rh haplotypes| Short symbol* | CDE nomenclature | Frequency # | | R1 | CDe | 40.8% | | r | cde | 38.9% | | R2 | cDE | 14.1% | | R0 | cDe | 2.5% | | r'' | cdE | 1.2% | | r' | Cde | 1.0% | | RZ | CDE | rarer | | ry | CdE | rarer |
* Symbols based on the work of Wiener and Race. R implies
that the gene determines D and r that it does not.
# These frequencies, for an English population, are derived from Race. Normal procedure When considering the ABO group, blood for transfusion should, whenever
possible, be group identical. In cases where this is not possiblegroup compatible blood, that is blood, the RBCs of which, do not carry
Ags against which the recipient has Abs. Table 2 shows which alternative ABO
groups are compatible with the ABO group of the patient. Table 2. ABO compatible groups| Patient's Blood
Group | Patient may
Receive Blood of Group | | O | A | B | AB | | O | Yes | NO | NO | NO | | A | Yes | Yes | NO | NO | | B | Yes | NO | Yes | NO | | AB | Yes | Yes | Yes | Yes |
Blood for transfusion should be of the same Rh D group as
the patient, that is to say patients with the D Ag should receive Rh (D) Pos
blood and those with the d Ag should receive Rh (D) Neg blood. In cases
of extreme emergency, when no Rh (D) Neg blood is available, it is permissible
to give Rh (D) Pos blood to males and females over the age of 50 years, if they
have never received Rh (D) Pos blood before and, in the case of females, they
have not developed anti-D Abs during a pregnancy. On no account should Rh (D)
Pos blood be given to females under the age of 50 years because of the danger
of raising Abs which could lead to HDN in a future pregnancy. There are 19 other major blood group systems, but their
importance lies only in their ability to produce transfusion reactions (HTRs)
and/or HDN. Table 3 lists the most common Abs and divides them by their ability
to cause a haemolytic transfusion reaction and/or HDN. Table 3 - Clinical significance of other blood group systems| Clinical Significance | Group | HTR | HDN | | Major | Kell (K/k) | Severe | Severe | | Duffy
(Fya/Fyb) | Severe | Mild | | Kidd
(Jka/Jkb) | Severe | Rare | | Moderate | U | Occ Severe | Nil | | Lewis
(Lea/Leb) | Moderate | Nil | | MNSs | Rare | Nil | | Lutheran
(Lua/Lub) | Rare | Nil | | Cartwright (Yt) | Rare | Nil | | Minor | P
(P/p/P1/Pk) | v.Rare | Nil | | Xg | Nil | Nil | | HI/I/i | Nil | Nil | | Scianna (Sc) | Nil | Nil | | Dombrock (Do) | Nil | Nil | | Colton (Co) | Nil | Nil | | Gerbich (Ge) | Nil | Nil | | Cromer (Cr) | Nil | Nil | | Cost (Cs) | Nil | Nil | | Gregory (Gy) | v.v.Rare | Nil | | Wright
(Wra/Wrb) | Nil | Nil |
Problems
Transfusion Reactions These, which are listed in Table 4, are probably the most frequent adverse
reactions to blood transfusion. An acute intravascular HTR, which is frequently
fatal, is the most important, but fortunately the most infrequent. Such
reactions most commonly occur due to the transfusion of blood incompatible by
the ABO system. The reaction usually occurs within the first 5 to 10 minutes of
a transfusion. The incompatible RBCs lead to activation of the complement and
coagulation systems. This in turn cause shock, DIC and renal damage and is
manifested by dyspnoea, chest pain, fever, oliguria, hypotension and later
haemoglobinuria. Delayed HTRs are not usually fatal and often are only
discovered when the patient's haemoglobin level and haematocrit fail to
demonstrate the expected post-transfusion rise. However the patient will have
been primed and will have formed Abs to the specific Ag and a further
transfusion of blood, incompatible to that Ag could lead to an acute
intravascular HTR. Table 4 - Immunological and Allergic Reactions| 1. Red Cells. | a. Acute intravascular haemolytic. | | b. Delayed extravascular. | | 2.White Cells | a. Febrile reactions. | | | b. Graft-v-host disease. | | | c. Transfusion related acute lung injury (TRALI) | | 3. Platelets. | a. Post transfusion purpura. | | | b. Refractoriness to platelet transfusion. | | 4. Miscellaneous | including anaphylactic, urticarial and pyrexial. |
White cell reactions, with the exception of graft-v-host
disease and TRALI, are usually of little clinical significance and are
manifested by a mild pyrexia and an urticarial reaction. These, as well as the
platelet and miscellaneous reactions, can usually be controlled by the
administration of an anti-pyretic and/or an anti-histamine. Haemolytic disease of the New-born HDN was a common cause of peri-natal death before the introduction of the
routine administration of anti-D Ig to Rh (D) Neg mothers who had delivered a
Rh (D) Pos child. Other Rh Abs are now more of a problem with anti-c and
anti-E being the most prominent. If blood is required for an exchange
transfusion, fresh whole blood, less than 5 days old, should be supplied. RBCs
in SAG-M, or any other optimal additive solution, are not suitable for exchange
transfusions. In all of these cases, it is advisable to discuss the matter with
the BCF Clinical Director. Patient with preformed antibodies The first point to evaluate is the significance of the Ab. Table 3 lists
the most common Abs and divides them by their clinical significance. Those that
do not bind complement or are only active at a thermal range below
300C are of little or no clinical significance and can usually be
ignored. In cases where the Ab is active at 370C and can cause an
acute haemolytic reaction, the BCF Authorised Blood Bank should be contacted
and blood, which lacks the Ag against which the Ab is directed, should be
requested. If no such blood is available the case should be discussed with the
BCF Clinical Director before any further action is taken. Numerical notation for the ABO system Soon after Landsteiner described the ABO system, 2 other workers described
the same system, but gave the groups a numerical notation. Moss1, in
the USA, described Group O as Group IV and AB as Group I, whereas
Jansky2, in Europe, described Group O as Group I and AB as Group IV.
Both systems described Group A as Group II and Group B as Group III. Some
hospitals in Eastern Europe still use the numerical notation. Before ordering
blood it is vital to establish which notation the doctor is using. Asking for
the blood group distribution within that country best does this. Whichever
numerical group is the commonest, this group will be Group O, then A followed
by Group B with Group AB being the least common. These 2 notations should not
be confused with the new 6-figure notation, which is being developed by the
International Committee for Standardisation in Haematology. References 1. Moss WL. Studies on isoagglutinins and
isohaemolysins. Bulletin John's Hopkins Hospital.
1910;21:63-70.
2. Jansky J. Haematologicke studie u. psychotiku. Sb. Klin. Praza
1907;8:85-139 © The Blood Care Foundation |